Jason V. Coloma's most recent trade in Maze Therapeutics Inc. was a trade of 30,311 Common Stock done at an average price of $30.0 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 01 Jul 2026 | 30,311 | 288,768 | - | 30.0 | 907,921 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 01 Jul 2026 | 2,593 | 23,337 | - | 30.0 | 77,726 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.44 per share. | 01 Jul 2026 | 1,597 | 287,171 | - | 30.4 | 48,606 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.05 per share. | 22 Jun 2026 | 23,865 | 319,079 | - | 26.0 | 621,674 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 Jun 2026 | 2,040 | 25,930 | - | 26 | 53,040 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 Jun 2026 | 1,953 | 342,944 | - | 26.0 | 50,781 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.20 per share. | 01 Jun 2026 | 6,090 | 344,897 | - | 26.2 | 159,537 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.24 per share. | 01 Jun 2026 | 553 | 27,970 | - | 26.2 | 14,511 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 22 May 2026 | 25,582 | 350,987 | - | 26.0 | 665,516 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 May 2026 | 4,504 | 376,569 | - | 26 | 117,104 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 May 2026 | 2,478 | 28,523 | - | 26 | 64,428 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 15 May 2026 | 1,822 | 381,073 | - | 26 | 47,372 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 15 May 2026 | 116 | 31,001 | - | 26 | 3,016 | Common Stock |
| Maze Therapeutics Inc | Jason V. Coloma | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2025 | 100,000 | 100,000 | - | - | Restricted Stock Units |